The proteomic LC-MS strategy revealing autoimmune mechanisms with new clarity for clinical research
Integrated proteomics and multiomics strategies are transforming the way researchers investigate immune dysregulation and disease mechanisms.
Tu, 19.5.2026 17:00 CEST
SelectScience
Preparing for Next Generation Evosep Proteomics
Get an exclusive pre-ASMS 2026 sneak peek into how Evosep is driving the next phase of proteomics standardization, showcasing advancements in Evotip-based sample prep and integrated workflows.
Th, 28.5.2026 16:00 CEST
Evosep Biosystems
Advancing PFAS biomonitoring: What we measure and why it matters
Explore how advanced LC-MS/MS, HRMS, and multi-omics reshape PFAS biomonitoring and health-risk assessment. Expert panel connects analytical science with clinical and regulatory decision-making.
Fr, 29.5.2026 17:00 CEST
SelectScience
Raising the Bar: Quality Assurance and Data Integrity in MALDI MSI
Join US HUPO experts to explore quality assurance and data integrity in MALDI MSI, covering best practices for reliable imaging workflows and reproducible spatial omics data.
RECORD
|
Already taken place Th, 7.5.2026
US HUPO
Transform Your Daily Lab Operations with Automation - Proteomics Workflows
Explore how automated liquid handling improves reproducibility, scalability, and efficiency in proteomics workflows across digestion, desalting, and peptide analysis.
RECORD
|
Already taken place Th, 7.5.2026
Waters Corporation
Next-Gen HCP Analysis in Biopharma
Discover how LC-MS is advancing biopharma workflows through scalable, high-throughput proteomics.
RECORD
|
Already taken place Th, 30.4.2026
Evosep Biosystems
Bridging Molecules and Genes: Integrating MALDI Imaging and Spatial Transcriptomics on a Single Tissue Section
Explore how integrating MALDI Imaging with spatial transcriptomics reveals tissue heterogeneity, molecular gradients, and disease-relevant patterns through advanced multimodal workflows.
RECORD
|
Already taken place Th, 30.4.2026
Bruker
High-throughput activity based protein profiling - Systematic mapping of covalent drug-protein interactions on a proteome-wide scale
Part 3 of the Chemoproteomics Master Class highlights activity-based proteome profiling and covalent screening to accelerate target identification and drug discovery using scalable MS workflows.
RECORD
|
Already taken place Th, 23.4.2026
Thermo Fisher Scientific
From experts to applications: Screening protein-drug interactions with HT-PELSA
Part 2 of the Chemoproteomics Master Class explores HT-PELSA with Orbitrap Astral MS, showing peptide-level ligand binding analysis for target discovery, specificity, and drug pipeline insights.
RECORD
|
Already taken place We, 22.4.2026
Thermo Fisher Scientific
Mass spectrometry strategies to power drug discovery
In this first master class session, explore how advanced mass spectrometry strategies are powering the next generation of drug discovery through chemoproteomics.
RECORD
|
Already taken place Tu, 21.4.2026
Thermo Fisher Scientific
Related content
News from LabRulezLCMS Library - Week 20, 2026
We, 13.5.2026
LabRulez
A comprehensive guide for selecting the appropriate HPLC detector
We, 13.5.2026
KNAUER
Tracking unspliced RNA: Professor Rumlová studies how retroviruses “hack” cells